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• HIV is an intracellular pathogen that hijacks the cellular machinery
• HIV causes a persistent infection under antiretroviral treatment









Examine transcriptome of CD4 T cells in search of host gene expression 
signatures involved in HIV persistence
Transcriptome correlates per marker
Mean (CI)
Viral load 0.24 (0.17-0.31)
TxInitiation (Years) 2.74 (2.11-3.36)
TxTime (Years) 1.61 (1.56-1.67)
HIV RNA 1906.22 (1436.81-2375.63)
HIV DNA: Pol 807.17(492.07-1122.27)
HIV DNA: 2 LTR 94.10 (54.21-133.99)
Conclusion
HIV patient characteristics and quantification of HIV markers
• This study reveals associations between  
host genetic pathways and HIV persistence
• Especially HIV RNA levels were correlated 
with following pathways: 
Notch, p53 pathway, RIG-I and EDG1-
induced T cell exhaustion
• HIV DNA levels correlated with PDCD1 and 
ST3GAL5 genes which indicate clonal 
proliferation as hallmark of HIV persistence 
• Treatment initiation was associated with 
pathways useful for immunotherapy: p53, 
mTOR
• Genes with RNAseq counts >10 Reads 
Per Kilobase Million across samples  
were analyzed: 9543 genes expressed
• CD4+ T cell transcriptomes were 
correlated with reservoir markers and  ART 
initiation timing in a guilt-by-association 
manner and involved the construction of 
correlation matrices (Pearson) with 
subsequent gene set enrichment analysis
• Significance was determined using a False 
Discovery Rate adjusted p-value (q-value) 
cutoff of 0.05. Gene sets were retrieved 
from the molecular signature databases: 



















































































Viral load: log(copies)/mL plasma
HIV RNA, DNA & 2LTR: copies/106 PBMCs
